GSK Extends Adverse-Event Pharmacogenomics Pact with FGT | GenomeWeb

NEW YORK, May 25 (GenomeWeb News) - First Genetic Trust said today that it will use its enTrust genetic banking platform in a research collaboration with GlaxoSmithKline to study the relationship between genetic variations and certain adverse drug reactions.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.